The 14th EACPT Congress was held from 29th June to 2nd July in 2019
in Stockholm as a partnership between the EACPT and the Swedish Society for
Pharmacology, Clinical Pharmacology and Therapeutics.
The term gut microbiota describes the population of microbes living in our intestines. Gut microbiota are being increasingly recognised as important contributors to a wide range of human diseases, from disorders of the gut to cancers and neurological disease.
Gut microbiota also contribute to drug response and to risk of adverse drug effects. Gut microbiota also provide a source of potential treatments.
In this short video you can hear keynote EACPT Congress speaker Professor Harry Sokol from Paris discuss the importance for clinical pharmacologists, other health professionals and patients of understanding emerging key roles for gut microbiota in serious diseases and their treatments.
Discussants
Professor Harry Sokol, Hôpital Saint-Antoine and Sorbonne University, Paris, France
in discussion with
Professor Tabassome Simon, EACPT Past-President
The term gut microbiota describes the population of microbes living in our intestines. Gut microbiota are being increasingly recognised as important contributors to a wide range of human diseases, from disorders of the gut to cancers and neurological disease.
Gut microbiota also contribute to drug response and to risk of adverse drug effects. Gut microbiota also provide a source of potential treatments.
In this short video you can hear keynote EACPT Congress speaker Professor Harry Sokol from Paris discuss the importance for clinical pharmacologists, other health professionals and patients of understanding emerging key roles for gut microbiota in serious diseases and their treatments.
Discussants
Professor Harry Sokol, Hôpital Saint-Antoine and Sorbonne University, Paris, France
in discussion with
Professor Tabassome Simon, EACPT Past-President
The next EACPT Congress
The next EACPT biennial congress will be held in Athens in June 2019. The programme will provide an international scientific and educational forum for discussion of clinical pharmacology and therapeutics, including personalised pharmacotherapy. See more on our website.
Joining the EACPT
Anyone from anywhere in the world with a professional interest in clinical pharmacology and therapeutics can now join the EACPT as an Individual Associate member.
Membership benefits include:
* Discounted registration fees for EACPT meetings
* Online subscription to the EACPT Official journal: the European Journal of Clinical Pharmacology
* Access to the EACPT’s worldwide network of Individual Associate Members
* Active involvement in EACPT
25th Anniversary
The EACPT was founded 25 years ago and now includes as members all major national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth. Find out more about the EACPT ...
Future EACPT Congresses
2021 Athens
2023 Rotterdam
2025 Helsinki
No comments:
Post a Comment